Sava Revenue and Competitors
Estimated Revenue & Valuation
- Sava's estimated annual revenue is currently $22.1M per year.
- Sava's estimated revenue per employee is $270,000
Employee Data
- Sava has 82 Employees.
- Sava grew their employee count by -8% last year.
Sava's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder and CMO | Reveal Email/Phone |
2 | Founder | CEO | Reveal Email/Phone |
3 | Director Marketing | Reveal Email/Phone |
4 | Customer Service Team Manager | Reveal Email/Phone |
5 | Brand Manager | Reveal Email/Phone |
6 | Operations Manager | Reveal Email/Phone |
7 | Sr. Fulfillment Operations Manager | Reveal Email/Phone |
Sava Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.1M | 33 | -40% | N/A | N/A |
#2 | $47.6M | 164 | 20% | $20M | N/A |
#3 | $37.3M | 138 | -3% | N/A | N/A |
#4 | $10.1M | 49 | 0% | $175.5M | N/A |
#5 | $45.1M | 152 | -3% | N/A | N/A |
#6 | $23.8M | 88 | 9% | N/A | N/A |
#7 | $12.6M | 52 | -5% | N/A | N/A |
#8 | $86.5M | 298 | 0% | $12.3M | N/A |
#9 | $2.4M | 15 | -12% | N/A | N/A |
#10 | $15.3M | 51 | 42% | $29M | N/A |
What Is Sava?
SAVA is a curated marketplace for cannabis goods available for delivery throughout California.
keywords:N/AN/A
Total Funding
82
Number of Employees
$22.1M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sava News
2022-04-17 - Cassava Sciences (NASDAQ:SAVA) has More Than Enough Funding to Function
Until the Approval Process is Finished, but Investors may Need to be Ready
for a Long Wait
Cassava Sciences, Inc.'s (NASDAQ:SAVA) a clinical stage biotechnology company, is developing a drug for Alzheimer - a neurodegenerative...
2022-04-17 - Hot Stocks: Homebuilders rally; CMPI, ACC jump on merger deals; SAVA falls
to new low
Homebuilders rallied on signs of continued demand in the housing market. CMPI and ACC rose on separate deals to be acquired.
2022-04-17 - Wall Street darling Cassava Sciences is under fire as scientists question
trial irregularities
Cassava Sciences was one of the fastest growing companies in the world last year after promising trials for its Alzheimer's drug.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $11.5M | 82 | -2% | $120.7M |
#2 | $11.5M | 82 | 55% | $41.4M |
#3 | $11.5M | 82 | 11% | $80.4M |
#4 | $26.9M | 82 | 32% | $6.4M |
#5 | $10.7M | 82 | -1% | $68.3M |